SOURCE: Targeted Genetics

March 27, 2007 07:30 ET

Targeted Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-Ended 2006 Results on March 29, 2007

SEATTLE, WA -- (MARKET WIRE) -- March 27, 2007 -- Targeted Genetics Corporation (NASDAQ: TGEN) will report its fourth quarter and year-ended 2006 financial results on Thursday, March 29, 2007, before the open of the financial markets. Following the announcement, management will host a conference call and webcast discussion of the financial results and provide a general corporate update beginning at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time. You may access the live webcast via the "Events" section of the Company's website at or via telephone at 800.257.3401 (domestic) or 303-262-2125 (international).

Replay Access

Webcast replay will be available for approximately 90 days at; telephone replay will be available following Thursday's call at 12:00 p.m. ET through 11:59 p.m. ET, Sunday, April 29, 2007, by calling 800-405-2236 (domestic) or 303-590-3000 (international); passcode 11087268#.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contact:
    Stacie D. Byars
    Director, Communications
    Targeted Genetics Corporation
    (206) 521-7392